Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Pediatric Oncology
•
Thrombosis
•
Hematology
•
Pediatric Hematology
•
Benign Hematology
•
Hemostasis/Thrombosis
Are there any circumstances where you would consider bridging for patients on DOACs?
What if the surgery is within 30 days of the blood clot?
Related Questions
For patients with incidental findings of venous thromboembolism during workup of a treatable malignancy, how do you approach discontinuation after the treatment is complete?
For a patient with May-Thurner syndrome and DVT, would you recommend anticoagulation for 3-6 months or indefinitely?
Do you repeat images in patients with venous thrombosis to inform decision about duration of anticoagulation?
Are SCDs contraindicated in patients with acute DVTs?
In a young female with severe osteoporosis due to congenital estrogen deficiency, can estrogen be prescribed if genetic testing for congenital disorders reveals a heterozygous Factor V Leiden mutation?
What is the ideal period to wait until curative surgery for patients with acute pulmonary embolism and solid malignancy?
How should elevated PT of unclear etiology and significance be evaluated?
Do you use FVIII levels to differentiate between DIC and coagulopathy of liver disease?
Would you use PCC for clotting factor repletion in acute life threatening hemorrhage in a patient with elevated INR from coagulopathy of liver disease?
Would you anticoagulate a patient with splenic infarctions in the setting of CMV viremia?